We suspected that Cabergoline repressed the activity of the natural inhibitor of the Wnt/β-catenin pathway, DKK-3, which is reported to exert significant antitumor efficacy by suppressing the activity of the Wnt/β-catenin pathway in multiple types of malignant tumors [43,44]. This evidence concerns the gene DKK3 and cancer.